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and thorax pain: a case report
Clinton J. Daniels1,2,3*, Pamela J. Wakefield1,2 and Glenn A. Bub1,2
Abstract
Background: A case of metastatic carcinoma secondary to urothelial carcinoma presenting as musculoskeletal pain
is reported. A brief review of urothelial and metastatic carcinoma including clinical presentation, diagnostic testing,
treatment and chiropractic considerations is discussed.
Case presentation: This patient presented in November 2014 with progressive neck, thorax and upper extremity
pain. Computed tomography revealed a destructive soft tissue mass in the cervical spine and additional lytic lesion
of the 1st rib. Prompt referral was made for surgical consultation and medical management.
Conclusion: Distant metastasis is rare, but can present as a musculoskeletal complaint. History of carcinoma should
alert the treating chiropractic physician to potential for serious disease processes.
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Background
Urothelial carcinoma (UC), also known as transitional
cell carcinoma (TCC), accounts for more than 90 % of
all bladder cancers and commonly metastasizes to the
pelvic lymph nodes, lungs, liver, bones and adrenals or
brain [1, 2]. The spread of bladder cancer is mainly done
via the lymphatic system with the most frequent location
being pelvic lymph nodes. Bladder cancer is the most
common malignant disease of the urinary tract with a
higher incidence in older age and more prevalent in men
than women [3]. There is a higher prevalence in white
persons; however, delayed diagnosis has lead to higher
mortality rates in black persons [4]. More than 80 % of
skeletal metastases are from carcinomas of the lung,
breast and prostate with bladder tumors responsible for
just 4 % of all bone metastases [5, 6]. Although uncom-
mon, studies confirm that bone is the preferred site of
metastasis (35 %) of UC outside of the pelvis, with the
spine being most common site (40 percent of bone
metastases) [7]. The cervical spine is only affected in 8
to 20 % of metastatic spine disease cases [8, 9]. The most
serious complication of UC is distant metastasis—with
higher stage cancer and lymph involvement worsening
prognosis and cancer survival rate [10]. The 5-year
cancer-specific survival rate of UC is estimated to be
78 % [10, 11].
Neck pain accounts for 24 % of all disorders seen by
chiropractors [12]. Although infrequently encountered,
malignancy and infiltrative processes are a potential
pathological source of neck pain [13]. Cancer is among
the most common life threatening conditions presenting
to chiropractic treatment facilities, with 58.9 % of
chiropractors self-reporting identification of previously
undiagnosed carcinomas [14]. A recent systematic
review identified more than 60 published cases of di-
verse cancers recognized by chiropractic physicians [15].
The objective of this case report is to describe a patient
presenting for chiropractic care with neck, arm and
thorax pain due to metastatic disease secondary to
urothelial carcinoma and provide brief review including
clinical presentation, diagnosis, and treatment.
Case presentation
History
An 81-year-old white male presented to the Saint Louis
Veterans Health Affairs chiropractic clinic in November
2014 with a referral for low back pain and he described
additional complaints of neck pain, upper thoracic pain,
* Correspondence: Clinton.daniels@logan.edu
1Chiropractic Clinic, VA St. Louis Healthcare System, 1 Jefferson Barracks Rd,
Saint Louis, MO, USA
2Logan University, College of Chiropractic, 1851 Schoettler Rd, Chesterfield,
MO, USA
Full list of author information is available at the end of the article
© 2016 Daniels et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Daniels et al. Chiropractic & Manual Therapies  (2016) 24:14 
DOI 10.1186/s12998-016-0097-8
radiating numbness, tingling and pain into the left arm,
and pain that radiated into his left lateral and anterior
chest wall. Coughing and sneezing significantly increased
his pain in all areas of complaint and he denied chest
pain and shortness of breath. Relevant medical history
included concurrent care for high-grade papillary transi-
tional cell carcinoma (TCC) of the bladder, and presence
of a pacemaker. He was a 50-year non-smoker, but with
a 30-pack year history of cigarette use.
His bladder cancer was diagnosed approximately one
year prior after he presented with gross hematuria. Cyst-
oscopy confirmed the presence of an 8 mm papillary
tumor near the right ureteral opening and trigone, and a
second cystoscopy identified a 5 mm mass on the left
lateral bladder wall. Two prior biopsy and transurethral
resections of bladder tumor (TURBT) procedures had
been performed. Pathology report revealed high-grade
transitional cell carcinoma that invaded subepithelial
connective tissue, but was negative for muscular in-
filtration. Upon presenting for chiropractic care he was
in the process of completing a second round of Bacillus
Calmette-Guérin (BCG) immunotherapy.
Diagnosis and management
Cervical radiographs taken one week prior to presenta-
tion were read as moderate degenerative changes of the
cervical spine with moderate carotid bulb atherosclerosis
(Fig. 1). Physical examination revealed tenderness to
touch of cervical paraspinal muscles and left upper tra-
pezius, and diminished light touch of the left upper ex-
tremity. Left anterior chest wall pain was reproduced
with manual over pressure of the left lower cervical
spine. The provider could not clearly identify the cause
of the upper back, chest and arm pain and did not
provide any treatment to the cervical region. MRI was
contraindicated due to the presence of an implanted
pacemaker. Computed tomography was obtained; multi-
planar multidetector CT images revealed a large destruc-
tive soft tissue mass along the leftward aspect of C6-T1
with frank osseous destruction of the vertebral bodies
and transverse processes (Fig. 2). An additional lytic
lesion was identified within the first right rib (Fig. 3).
The patient was sent to the emergency department for
stabilization and consultation with an orthopedic sur-
geon. He selected non-operative management and was
stabilized with a Miami-J cervical collar. The patient ex-
pired 4-weeks following the discovery of these lesions on
the CT scan.
Discussion
Metastatic disease of the cervical spine can present with a
variety of clinical signs and symptoms; including mechan-
ical, nonmechanical, and referred pain due to pathologic
fracture and/or neurologic dysfunction from cord or nerve
root compression. Localized nonmechanical pain is the
most common complaint, and is often described as not
being related to any activities, progressively worsening,
and exacerbated in the evening [16]. For patients with a
history of carcinoma and a new onset of nonmechanical
pain it is imperative to rule out the presence of metastatic
disease [17–19]. Our patient’s history of UC, cigarette use,
and new onset of neck pain was a red flag for potential
pathologic processes.
There is a clear correlation between smoking and the
risk of developing bladder carcinomas [20]. Cigarette
smoking is credited as responsible for more than 50 % of
cases within the developed world [21], and a four to
seven times greater risk than nonsmokers [22, 23]. An
additional 5 to 10 % of cases can be linked to occupa-
tional exposures, such as aromatic amines used in
Fig. 1 AP cervical radiograph taken in 2010 (Left) AP cervical radiograph demonstrating missing left C6 pedicle and articular pillar taken in 2014 (Right)
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manufacturing of chemical dyes and pharmaceuticals,
and in gas treatment plants [24, 25]. While our patient
was a long-term non-smoker his prior smoking may still
have been contributory to disease development.
The most common symptom of patients with urothe-
lial carcinomas is painless hematuria. Gross blood
throughout urination is suggestive of bladder cancer
[20]. Our patient sought medical care in the presence of
hematuria and this ultimately lead to his cancer diagno-
sis. Early stage, local bladder disease, or carcinoma in
situ, most commonly presents with urinary frequency,
urgency and other signs of bladder irritation [20]. If the
lesion is located near the urethra or bladder neck then
the patient may experience obstructive symptoms. Signs
of obstruction include decreased force or intermittent
stream, sensation of incomplete voiding and straining.
Pain may be present in the flanks with advanced stages
of disease caused by urethral obstruction. Physical pain
may also present in abdomen, pelvis, buttock or at dis-
tant bone sites [20, 26].
Practitioners should begin investigation of patients
with urinary symptoms with a thorough history of
cigarette smoking and occupational exposures. Physical
examination does not provide much insight for early
bladder cancer, however, palpable masses of the kidney
and pelvis may be detectable in later stages [20].
Urinalysis with urine microscopy and a urine culture is
first line screening to rule out infection and hematuria.
If bladder cancer is suspected, then urine cytology and
cystoscopy would be indicated. Urine cytology is a non-
invasive test that consists of sending urine sample to a
laboratory for pathologist assessment to identify and
monitor for high-grade tumors. Cytology interpretation
is user dependent [27] with a sensitivity for carcinoma in
situ of 28 to 100 % [28] and specificity exceeding 90 %
[29]. Cystoscopy is an office procedure performed under
local anesthesia, and is the mainstay of diagnosis and
surveillance [20]. This involves insertion of a hollow tube
with a lens (cystoscope) into the urethra and advanced to-
wards the bladder. The cystoscope provides information
on tumor location, appearance, and size. Bladder wash
cytology is very sensitive for carcinoma in situ and obvi-
ates the need for random bladder biopsies. Patients with
symptoms of bladder cancer should be evaluated with
cystoscopy and bladder wash cytology [30].
Patients with a known history of cancer presenting
with persistent neck pain (including mechanical and
nonmechanical) should be evaluated for pathologic pro-
cesses [16]. A history of nocturnal pain further escalates
the suspicion of a neoplastic process [16]. Early diag-
nosis can be aided with basic neurologic screening for
spasticity, hyperreflexia, Hoffman sign, and abnormal
plantar reflexes [31]. In our case, the patient presented
with vague mechanical symptoms and neurological symp-
toms that quickly progressed between visits—although
pathologic reflexes remained absent. Evaluation for
metastatic disease includes common laboratory tests such
as complete blood count, blood chemistry tests, liver
function tests, chest radiography, and CT or MRI [32].
Follow-up bone scan may be performed if in the presence
of symptoms indicating potential bone metastasis or
elevated alkaline phosphatase levels [20].
Men have a higher incidence of spinal metastases than
women, and individuals in the fourth and sixth decade are
most likely to be affected [33]. The main mechanisms by
which a lesion can metastasize to the spine are dependent
on the primary neoplasm and include: direct extension or
invasion, hematogenous metastasis, and cerebrospinal
fluid (CSF) seeding [16]. Direct extension occurs through
primary lesions becoming locally aggressive and extending
to involve bony spine. Hematogenous seeding is facilitated
by the vast arterial supply of the vertebra and via the
valveless venous drainage plexi such as Batson’s plexus.
Seeding of a primary lesion through the CSF occurs much
less frequently and is most often caused by surgical ma-
nipulation of cerebral lesions [34]. Post-mortem biopsy
was not performed on this patient, therefore it is not pos-
sible to definitively state that his cervical metastasis was a
direct result of his urinary carcinoma.
Fig. 2 Axial CT demonstrating destructive mass C6 left vertebral
body and transverse process
Fig. 3 Lytic lesion in right 1st thoracic rib
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Management of metastatic disease of cervical spine re-
quires a multidisciplinary approach. In general, nonsur-
gical management of metastatic spine is recommended
when tumor involvement has not resulted in spinal
instability, neurological involvement, and pain nonre-
sponsive to medical management [35]. Nonoperative
management consists of radiotherapy, chemotherapy,
hormonal therapy, and high-dose steroid therapy [16].
Radiotherapy is specifically aimed to reduce tumor size
and response to therapy varies widely depending on
tumor type. To reduce localized intramedually edema,
acutely presenting symptoms of cervical epidural spinal
cord compression by a neoplasm can be managed with
corticosteroids such as Dexamethosone [16]. Chemo-
therapy may be utilized as an adjuvant therapy to treat
the primary tumor(s), as it has no direct effect on spinal
instability [16]. Although not a primary method of treat-
ment, bisphosphonate use in the setting of metastatic
cervical spine disease is advocated to reduce the inci-
dence of skeletal-related events such as pathologic verte-
bral fractures and cord compression [16]. Surgery is
generally palliative and indicated in cases of neurologic
dysfunction, spinal instability, and intractable pain
(Table 1). In cases of metastatic tumor the most com-
mon surgical intervention is anterior cervical corpect-
omy with fusion. Laminectomy with fusion is used less
frequently as most lesions are located anteriorly. How-
ever, posterior decompression and stabilization may be
the best treatment option at the craniocervical junction
[16]. Detailed discussion of each individual therapy is be-
yond the scope of this paper and can be found elsewhere
[8, 36, 37] (Table 2).
The effectiveness of these treatment modalities and the
patient survival rate depends on the histological tumor
type, tumor stage, therapeutic control of the primary
tumor, and spread of the tumor [36]. Indications for treat-
ment are guided not simply by neurocompression, but
also by quality of life factors—such as pain and loss of
mobility. The oncology clinical decision process is further
hampered, as a surgical option is often inappropriate due
to possible comorbidities.
One of three cancer patients experience pain either
directly related to their lesion or as an adverse result of
cancer treatment—for instance radiation related fibrosis
and joint contracture or chemotherapy-induced neur-
opathy [38]. Chiropractic care with high-velocity manipu-
lation is widely considered an absolute contraindication
[39]. Potential diminished bone strength and integrity
from malignancy puts the patient at risk of skeletal-related
events with forceful treatments. Low force treatment tech-
niques such as mechanical-assisted manipulation methods
[40], myofascial release, stretching and gentle exercise
may be appropriate on a case by case basis as an adjuvant
for pain management [39]. While prudent use of chiro-
practic services in cancer patients may offer effective strat-
egies for reducing the pain and suffering, we do not
believe that any chiropractic care was appropriate for our
patient’s chief complaint.
Consent
Written informed consent could not be obtained. The
Saint Louis Veterans Health Affairs privacy officer and
Research Development Committee provided approval
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Conclusions
This case describes the presentation of metastatic urothe-
lial carcinoma as a source of neck, arm and thorax pain.
Development of urothelial carcinoma is strongly corre-
lated with smoking and occupational exposures. Although
distant metastasis is rare, it can present as musculoskeletal
pain and it is not uncommon for previously undiagnosed
cases to present to chiropractic physicians.
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Table 1 Indications for neurosurgery in the presence of
malignancy [35]
Surgical Indications
• Pain due to mechanical compression of pain producing structures or
clear instability
• Symptomatic mechanical compression of neurostructures (neurological
deficit)
• Rapidly progressing neurological deficit due to mechanical compression
• Unknown primary tumor with clearly defined metastatic involvement
of the spine
• Radioresistant tumor
• Neurological deterioration or increasing pain during or after radiotherapy
(should be avoided by a careful evaluation of the tumor potential before
irradiation is decided)
Table 2 Treatment rationale for non-operative procedures
Treatment Purpose/Goal
Corticosteroid (i.e., Dexamethosone) Reduce intramedullary edema and
subsequent pressure
Chemotherapy/Hormone Therapy Treat or manage primary tumor
Irradiation Reduce tumor size
Bisphosphonates Prevent and/or reduce likelihood
of skeletal-related events
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